The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | P | Antiparasitic products, insecticides and repellents | |
| 2 | P01 | Antiprotozoals | |
| 3 | P01A | Agents against amoebiasis and other protozoal diseases | |
| 4 | P01AX | Other agents against amoebiasis and other protozoal diseases |
| Code | Title | |
|---|---|---|
| P01AX01 | Chiniofon | |
| P01AX02 | Emetine | |
| P01AX04 | Phanquinone | |
| P01AX05 | Mepacrine | |
| P01AX06 | Atovaquone | |
| P01AX07 | Trimetrexate | |
| P01AX08 | Tenonitrozole | |
| P01AX09 | Dihydroemetine | |
| P01AX10 | Fumagillin | |
| P01AX11 | Nitazoxanide | |
| P01AX52 | Emetine, combinations |
| Active Ingredient | Description | |
|---|---|---|
| Atovaquone |
Atovaquone is a selective and potent inhibitor of the eukaryotic mitochondrial electron transport chain in a number of parasitic protozoa and the parasitic fungus P. jiroveci. The site of action appears to be the cytochrome bc1 complex (complex III). |
|
| Chiniofon |
|
|
| Mepacrine |
|
|
| Nitazoxanide |
|
|
| Phanquinone |
|
|
| Tenonitrozole |
|
| Title | Information Source | Document Type | |
|---|---|---|---|
| ALINIA Tablet / Oral suspension | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| MEPRON Oral suspension | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| WELLVONE Oral suspension | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
